Cell Based Assays Market to be Worth US$ 19,710.7 Million by 2022

As per the projections of the TMR report, the demand in the global cell based assays market will expand at a healthy CAGR of 7.7% during the forecast period of 2017 to 2022. The revenue in the market for cell based assays, across the world, is estimated to be worth US$19,710.7 mn by 2022, substantially up from its evaluated valuation of US$13,576.7 mn in 2017. In the near future, most of the leading companies of this market are expected to invest on research and development in order to stay ahead of the curve. They are also expected to focus on emerging economies in Asia Pacific to gain market shares as well as indulge in collaborations and mergers.

Report Overview @ https://www.transparencymarketresearch.com/cell-based-assays.html

The growing prevalence of chronic diseases such as cancer, arthritis, cardiovascular, diabetes, and epilepsy, increased availability of funding for research along with government support, incrementing preference for cell-based assays, and increasing drug discovery activity are some of the key factors augmenting the demand in the global cell based assays market. Cell based assays can be of various types, ranging from cytotoxic assays to cell proliferation, and are used to check drug stability, drug potency, and drug purification, as well as in production support.

Cell based assays are primarily used by companies operating in the fields of pharmaceutical and biotechnology and has numerous possibilities for the future, promising to revolutionize the therapeutics of life-threatening diseases such as cancer and immunology. The global cell based assays market is also gaining traction from the emergence of novel technologies in science and medicine. For example, Symcel, the company who developed calScreener - a cell based assay tool for real-time cellular bioenergetic measurements, recently associated with Colzyx, working together on a goal to identify and test 25 different new collagen VI derived antimicrobial peptides. These recently discovered peptides are first of its kind and may be able to kill bacterial growth in different ways.

Growing adoption of cell assay based high-throughput screening methods of drug compound screening, replacement of in vivo toxicity testing by in vitro testing methods, and emergence of new branches in bio-science such as synthetic biology, which depends on accurate cell testing, are some of the other factors that will ensure a healthy future growth of the cell based assay market. On the other hand, high cost of instruments and restrictions pertaining to the usage of reagents are challenging the cell based assays market from attaining its true potential.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=846

Based on product-type, the global cell based assays market gains maximum demand for reagents and consumables, a segment that constituted 32.1% of the total demand in 2017 and produced a revenue of US$4,356.6 mn the same year. The demand for reagents and consumables segment of the cell based assays market has been anticipated to increment at a CAGR of 7.5% during the forecast period of 2017 to 2022. Geographically, the TMR report picks out North America as the most lucrative region, which is projected to exhibit an above-average CAGR of 7.5% during the said forecast period. North America cell based assays market is estimated to be worth US$7,672.5 mn by 2022.

A fresh study by Transparency Market Research (TMR) has observed that the global cell based assays market is divided among a large number of players, and the fragmented scenario will sustain in the near future too as more and more pharmaceutical and biotechnology companies make a foray in this developing market with their financial might. Having said that, a few companies do hold stronger position than the rest in the global cell based assays market, such as GE Healthcare Inc., Lonza Group Ltd., Danaher Corporation, Becton, Dickinson and Company, Charles River Laboratories, Thermo fisher Scientific Inc., Merck & Co Company, Cell Signaling Technology, Inc., PerkinElmer Inc., Promega Corporation, Marin Biologic Laboratories, Essen BioScience Inc., Cell Biologics Inc., BioAgilytix Labs., Enzo Life Sciences, Inc., Aurelia Bioscience Ltd., Selexis SA, and QGel SA.

Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=846&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Genomics Personalized Health Market is Estimated to Reach US$ 25,112.5 Million by 2025

As per TMR, the global genomics personalized health market is likely to rise at a cracking pace of 14.9% CAGR between 2017 and 2025, for the market to become worth US$25,112.5 mn by the end of 2025. The market stood at a valuation of US$7,243.0 mn in 2016.

Report Overview @ https://www.transparencymarketresearch.com/personalized-genomics-market.html

The global genomics personalized health market is majorly driven by the increasing investments for research and development of biomarkers. Biomarkers have significance for identifying the physiological state of an organism suffering from a certain disease. The increasing prevalence of chronic diseases such as cancer and diabetes has led to an increased demand for disease diagnostics, which is indirectly benefitting the genomics personalized health market. For instance, the unexpected increase in Ebola incidence has benefitted players in the global genomics personalized health market to introduce an effective course of treatment.

Apart from this, the growth of the pharmaceutical sector and prediction and assessment of response to treatment are leading to a surged demand for genomics personalized health solutions. Burgeoning development in the molecular biology sector coupled with technological innovations are also acting in favor of the global genomics personalized health market. Lastly, the growing geriatric population worldwide that will present a considerable demand for personalized medication is expected to aid the growth of genomics personalized health market in the upcoming years.

The key segments of the market based on technology are NGS platforms, microarray, RT-PCR, genetic analyzers, and others. Of them, NGS platform held a significant share of more than 32.0% share of the market in 2016. Diagnostic centers and academic and research institutes are the leading end-use segments with the segments collectively accounting for a share of almost 88.0% in 2016.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12197

Amongst the key regional segments, North America genomics personalized health market held the leading share in 2016, trailed by Europe. The region is expected to acquire the leading 41.6% share of the market by the end of 2025. In the coming years, however, Asia Pacific is expected to surpass in terms of growth rate over the forecast period mainly because of increasing demand for innovative technology.

On the other hand, amongst a few factors restraining the growth of this market, a complicated regulatory framework that causes a delay in the approval of newer methods is emerging to be a major roadblock to this market. Furthermore, lack of favorable reimbursement policies is expected to prevent end users from opting for personalized medication. The trend will be more pervsive in emerging economies where the healthcare sector is still in developmental phase.

The global market for genomics personalized health is largely occupied by some of the leading vendors, observes a new report by Transparency Market Research (TMR). The topnotch players that include QIAGEN, Thermofisher Scientific, F. Hoffman-La Roche Ltd., and Illumina Inc. held close to 65% of the market in 2016. The market, however, displays intense competition among market participants in a bid to garner larger market share. Key market players are pouring in money into research and development to cater to the rising demand for technologically advanced tests.

Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=12197&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Microfluidics Market is Estimated to be Worth US$ 12.45 Billion by the End of 2025

According to TMR, the global microfluidics market is projected to expand at CAGR of 11.4% from 2017 to 2025. The global market for microfluidics stood at US$4.76 bn in 2016 and is forecast to touch a valuation of US$12.45 bn by the end of 2025.

The drive for the sales of microfluidics platforms stems from a substantial demand for cost-effective diagnostic procedures that ensure economical use of reagents and require small-sized medical devices. The growing demand for low-cost microfluidics in the point-of-care settings is a notable factor boosting the market. In addition, the rising popularity of point-of-care testing for the diagnosis of a number of chronic ailments, including cardiovascular ailments, diabetes, and cancer is boosting the market. The advent of low-cost point-of-care diagnostics supported by microfluidics technologies has immensely benefitted patients and clinicians alike, notably in various emerging economies of Asia Pacific.

Report Overview @ https://www.transparencymarketresearch.com/microfluidics-market.html

The burgeoning geriatric population in several developing and developed nations is stoking the need for microfluidics platforms that offer rapid and reliable diagnosis. Furthermore, the rapid strides made by genomics and proteomics in recent years is a notable factor providing a robust fillip to the growth of the market.

The protracted approval processes by various regional agencies, notably the U.S. FDA, has adversely affected the earnings of the market in recent years. Coupled with this, the elevated cost of instruments is a crucial factor likely to impede the growth of the market to an extent. Nevertheless, the use of polymers in the manufacturing of advanced microfluidic products is likely to bring the final price of microfluidics, which augurs well for the market.

In addition, a number of dynamic collaborations entered into by leading players is a significant factor expected to accentuate the growth of the market. In addition, R&D activities related to novel methods of drug delivery is anticipated to positively impact the global microfluidics market.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18716

The advent of low-cost microfluidics for point-of-care testing is expected to present lucrative avenues for market players in the coming years.

The various product types are microfluidic chips, cartridges and reagents, and instruments. Of these, the cartridges and reagents segment is predicted to lead the market and is estimated to garner a CAGR of 12.2% during 2017–2025. The dominance of the segment can be attributed to the vastly rising demand for these in assays and techniques.

Geographically, North America leads the global market and is predicted to account for a major share by the end of the forecast period. The launch of a wide range of novel technologies in point-of-care testing methods and the extensive demand for in-vitro diagnostics are key factors accentuating the growth of the regional market. Meanwhile, Asia Pacific is set to rise at a promising pace during the assessment period.

The global microfluidics market features a largely consolidated landscape, attributed to the marked presence of several globally prominent players. The top three players held a market share of 53.0% in 2016, finds Transparency Market Research (TMR). These leading players are Danaher Corporation, F. Hoffman-La Roche AG, and Thermo Fisher Scientific. They are broadening their product portfolio and consolidating their geographic presence, in a move to stay ahead of the pack, notes TMR. Several companies in the market are also focused on launching technologically-advanced products for a wide range of applications in areas such as drug discovery, therapeutic devices, and medical diagnostics. Such product innovations which includes low-cost point-of-care testing help them gain a significant share in the overall market.

Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=18716&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Neurovascular Stent Retriever Technology Market Growth Opportunities and Forecast Up to 2024

Ischemic stroke is currently one of the leading causes of death or disability within the western world. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee had previously stated that nearly 795,000 patients were experiencing stroke every year, and the number is shown to the be growing every year. One of the more effective treatments currently is the use of tissue plasminogen activators in systemic thrombolysis. Stent retrievers are a newer technology and form a part of mechanical thrombectomy.

Report Overview @ https://www.transparencymarketresearch.com/neurovascular-stent-retrievers-market.html

Stent retrievers are finding more and more value in the event of an acute embolic stroke, for restoration of flow and in thrombectomies. A large number of clinical tests and results are falling in favor of the more innovative designs in the global neurovascular stent retriever technology market and the ability of these technologies to swiftly and efficiently restore flow. They can also successfully retrieve clots from major intracranial arteries, ensuring a solid demand and growth rate for the global neurovascular stent retriever technology market.

According to WHO, there are 15 million people across the globe suffering from stroke each year. The incidence of obesity and diabetes has increased over the years and is responsible for the rising prevalence of strokes. Neurovascular stent retriever technology finds application in medical equipment used for the treatment of strokes. The American Heart Association and the American Stroke Association recommend the use of neurovascular stent retrievers for the treatment of strokes. This is driving the global neurovascular stent retriever technology market.

The global neurovascular stent retriever technology market is expected to witness a significant growth in the coming years owing to their use in the treatment of even the most serious cases of stroke with thromboembolic occlusion. The report segments the global neurovascular stent retriever technology market on the basis of technology, geography, and product. The major technologies studied in the report are embolization and coiling, neurothrombectomy, carotid artery angioplasty and stenting, and supporting technologies. The segmentation of the market is done so as to enable a detailed understanding of the performance of each segment of the global neurovascular stent retriever technology market.

The report is compiled through extensive primary research, including surveys, interviews, and observations of expert analysts. Secondary research methods that make use of trade journals, industry databases, and paid sources are also used. The report includes details about the competitive landscape of the global neurovascular stent retriever technology market and profiles key players operating in the market.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11195

Technological innovations and advancements in neurovascular stent retriever technology are driving the market. Advancements in neurovascular stent retriever technology are encouraged by various governments, especially in developed countries. This is because there has been a notable improvement in patients owing to the use of neurovascular stent retrievers, thus gaining government support. Moreover, the sedentary lifestyle and unhealthy eating habits of people worldwide are also boosting the global neurovascular stent retriever technology market. However, a dearth of skilled neurosurgeons, coupled with the high level of complexity involved with neurological surgeries, is hampering the growth of the market.

The global neurovascular stent retriever technology market is segmented on the basis of product into snares, suction and aspiration devices, flow diversion devices, embolic coils, clot retrievers, microcatheters, cerebral balloon angioplasty and stenting systems, support devices, embolic protection systems, and carotid artery stents.

By geography, North America leads in the global neurovascular stent retriever technology market owing to the easy accessibility to advanced healthcare options in the region. Favorable reimbursement policies and a strong presence of neurovascular stent retriever device manufacturers in North America are boosting the growth of the market in the region. Significant investments in research and development activities are also helping the market’s growth. Europe and Asia Pacific are the second and the third largest regional segments in the market. The market in Asia Pacific is expected to grow in the coming years due to the dynamic economies of India and China and the rising cases of strokes in the region. The increasing ability of the consumers in the region to afford advanced medical treatment methods is also behind the growth of the region in the neurovascular stent retriever technology market.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=11195&ltype=S

The report profiles the key players operating in the global neurovascular stent retriever technology market. The business and financial overviews of each of the companies are given. The challenges faced by the companies and the strategies adopted by them to stay at the forefront of the market are also given in the report. By offering details such as a company’s recent developments and product history, the report attempts to enlighten readers, helping them gain a competitive edge. The key players in the market are: Stryker, Meril Life Science Pvt .Ltd., Nitinol Devices & Components, Inc., Advent Devices Pvt. Ltd, Medtronic Plc, Norman Noble, INC., Hobbs Medical IN, STI Laser Industries, Ltd., and Akron Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Cochlear Implant Systems Market Trends & Opportunities with Forecast Up to 2025

A cochlear implant is an electronic medical device that transmits sound signals to the brain. With the cochlear implant, a person can achieve better sentence understanding as compared to hearing aids. At present, cochlear implants are the only effective means allowing the social interaction of individuals suffering from hearing loss. The first cochlear implant was approved by the FDA in 1984, which made 3M an industrial leader.

Report Overview @ https://www.transparencymarketresearch.com/cochlear-implant-systems-market.html

Increasing incidence of neonates born with hearing defects is driving the market cochlear implant systems. According to WHO hearing loss statistics, each year, approximately, 134 million children are born, out of which approximately 1 to 3 newborns per 1,000 are with hearing loss, which is treatable only with a cochlear implant. Thus, there is a need for a minimum of 134,000 cochlear implants annually. The number of cochlear implants is likely to increase to approximately 160,000 per year if the hearing loss is considered for both ears. Apart from the rising number of patients suffering from hearing loss, technological advancements, strategic initiatives by industry players, and favorable government regulations are driving the growth of the global cochlear implant systems market in 2016.

For instance, in1979, the University of Melbourne and Nucleus Limited got approval from the Australian Department of Productivity to manufacture and market 22 cochlear implants. In another event, the National Institutes of Health (NIH) funded the first consensus conference to speed up the acceptance of multi-electrode cochlear implants. Market players are focused on the development of devices with reduced noise, quickly chargeable, long battery life, and waterproof. According to the World Health Organization (WHO), the current production of hearing loss aids is only 10% of the actual need; thus, there is a lucrative opportunity for new players to enter the global cochlear implant systems market.

The global cochlear implant systems market has been segmented based on type of fitting, end-user, and region. Based on type of fitting, the market is segmented into unilateral implantation and bilateral implantation. The unilateral implantation segment dominates the global cochlear implant systems market owing to low cost. Unilateral implantation is common in adults. The bilateral implantation segment is expected to expand at a fast growth rate during the forecast period owing to rising demand for cochlear implants by pediatric patients suffering from hearing loss. Moreover, several countries are offering reimbursement only for bilateral implantation contributing to the growth of the segment. In terms of end-user, the market is segmented into hospitals, ENT clinics, and other end-users.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34124

The ENT clinics segment dominate the global cochlear implant systems market in 2016, owing to increasing patient population suffering from hearing loss, and growing patient preference towards treatment in ENT clinics in emerging countries. According to WHO estimates in 2012, out of the total worldwide population with hearing impairment, 91% were adults and 9% were children.

Geographically, the global cochlear implant systems market is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific region is expected to dominate the global cochlear implant systems market owing to the high prevalence of hearing defects in the region. Middle East & Africa region is expected to account for the second largest share in 2016. This is attributable to the highest incidence of otitis media, ear infections owing to lack of proper hygiene practices, and increasing pregnancy and genetic complications leading to hearing loss in neonates. Europe is the next largest market for cochlear implants owing to increasing geriatric population.

Key players operating in the global cochlear implant systems market include MED-EL, Cochlear Limited, Oticon Medical, William Demant Holding A/S, LSVT Global, Inc., PENTAX Medical, EBS Healthcare, Sonova, Gaes Medica, and Nurotron Biotechnology Co., Ltd.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=34124&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Operation Theatre Lights Market Comprehensive Analysis and Future Estimations 2025

Cavities in the human body are dark and can obstruct the visualization of lesions and minute body parts, making the surgical procedure difficult. Operating theatre (OT) lights are medical devices used to provide light for surgeons and staff during medical procedures. Operation theater lights have been an integral part of the OT. Technological advancements have led to the development of specialized OT lights to cater to the specific requirements depending on the type of surgery and OT specifications and dimensions. These lights are mounted on flexible arms, which can be moved to adjust and focus on an area requiring illumination. Choice of OT light depends on parameters such as luminescence, light temperature, and arm mobility.

Report Overview @ https://www.transparencymarketresearch.com/operation-theatre-lights-market.html

Rise in expenditure on development of health care infrastructure in the emerging markets is projected to increase the number of health care facilities. This is likely to drive the market. Stringent regulations and demand for safety in developed markets are likely to increase the consumption of these lights through regular replacement to improve OT suits. The number of ambulatory surgical centers is projected to rise in the developed markets owing to increase in demand and high operational margins.

This is estimated to propel the operation theater lights market during the forecast period. However fragmented market with many small and medium scale industry players on regional levels is projected to hamper growth of OT lights market in near future. Moreover, inclination toward minimally invasive surgeries as compared to open and invasive surgeries is anticipated to restrain the market during the forecast period.

The global operation theatre lights market can be segmented based on light source, design, end-user, and region. In terms of light source, the market can be divided into halogen and light emitting diodes (LED). The LED segment is likely to dominate the market during the forecast period due to long life, better illumination, less power consumption, and low temperature. Based on design, the market can be categorized into wall mounted, ceiling mounted, and floor standing OT lights. The ceiling mounted OT lights segment is likely to register strong growth during the forecast period as these occupy less space and offer better mobility.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34145

In terms of end-user, the market can be classified into hospitals, ambulatory surgical centers, and others. The others segment comprises specialty clinics and nursing homes. Large base of hospitals and perpetual rise in the same is projected to contribute for dominant share of hospitals in the global OT lights market. Increasing number of ambulatory surgical centers is estimated to fuel the ambulatory surgical centers segment.

Geographically, the global operation theatre lights market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold major share of the global market, owing to high adoption of technology and high expenditure on health care facilities by the public and private sectors. Europe is anticipated to account for a significant share of the global market during the forecast period, attributed to well-established hospitals in Western Europe and developing health care infrastructure in East and Central Europe. Asia Pacific is projected to be the fastest growing market for OT lights during the forecast period.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=34145&ltype=S

Major players operating in the global operation theatre lights market are Dr. Mach GmbH & Co. KG, STERIS plc, BiHealthcare, RIMSA, Drägerwerk AG & Co. KGaA, Stryker, Midmark Corp., DARAY, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trumpf Medical, BenQ Medical Technology, Allengers, and Brandon Medical Co Ltd., among others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Fecal Incontinence Market Key Developments with Forecast Until 2025

Fecal incontinence is associated with the inability of individuals to control bowel movements, causing unexpected leakage of stool leading to complete loss of bowel control. Fecal incontinence is also known as bowel incontinence. It is caused due to constipation, diarrhea, and nerve damage which is linked with aging. Fecal incontinence is of two types: urge incontinence (an individual is not able to resist the urge to excrete) and passive incontinence (an individual is not aware of the sensation before soiling oneself).

Report Overview @ https://www.transparencymarketresearch.com/fecal-incontinence-market.html

Fecal incontinence can be caused due to muscle damage associated with damage of anal sphincter. This type of muscle damage takes place during child birth. Nerve damage can also led to fecal incontinence leading to loss of control over anal sphincter. The primary reason for nerve damage can be diseases such as multiple sclerosis, diabetes, and Alzheimer’s. Other causes of fecal incontinence are surgery, rectal prolapse, and rectocele. Complications associated with fecal incontinence include emotional distress and skin irritation. Emotional distress is also linked with the loss of bowel control, leading to shame, embarrassment, anger, frustration, and depression.

Fecal incontinence diagnosis is carried out through medical examination test, which include digital rectal examination, balloon expulsion test, anal manometry, proctography, proctosigmoidoscopy, colonoscopy, and magnetic resonance imaging (MRI). Treatment of fecal incontinence involves usage of anti-diarrheal drugs such as loperamide hydrochloride, laxatives (psyllium), and injectable bulking agents such as hyaluronate sodium. Surgery can also be prescribed in certain adverse cases. Different types of surgical procedures used to treat fecal incontinence are sphincteroplasty, surgical correction of rectocele or hemorrhoids, sphincter replacement, colostomy, or bowel diversion. Around 1.4% of the general population over 40 years of age is affected by fecal incontinence and nearly 3% to 15% of the population is affected by constipation. According to the Continence Foundation of Australia, nearly 4.8 million people in Australia experience bladder or bowel control problems. Fecal incontinence affects nearly 20% of men and approximately 12.9% of women in Australia.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33698

Major drivers of the global fecal incontinence market are increase in prevalence of diseases which result in the loss of muscle control and lead to gastrointestinal disorders, rise in the pharmaceutical industry, surge in demand for fecal incontinence products, growing awareness about personal hygiene, rise in geriatric population, and technological innovation in continence product development. Factors restraining the market are social stigma, emotional distress, increasing cost of health care suppliers, inadequate knowledge about the treatment of fecal incontinence in developing countries, and stringent regulations and reimbursement policies.

The global fecal incontinence market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold a major share of the market in terms of revenue. Dominance of the region is attributed to higher acceptance of fecal incontinence products, increase in awareness, presence of major market leaders in the region, better health care facilities in terms of health care expenditure, and increase in prevalence of chronic diseases. The market in Europe trails closely behind the North America market.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=33698&ltype=S

The fecal incontinence market in Asia Pacific is expected to expand at a high CAGR during the forecast period due to rapidly increasing geriatric population, health care infrastructure, public and private collaboration to spread awareness among individuals about personal hygiene, higher rate of adoption of newer technology in product development, fast growing economies such as India, and expansion of business and product portfolio by major market players in the region. The market in Latin America and Middle East & Africa is expected to provide a lucrative growth opportunity during the forecast period due to favorable economic reforms in promoting the health care industry.

Major players operating in the global fecal incontinence market are Kimberly-Clark Corporation, Medline Industries Inc., Coloplast A/S, and B. Braun Melsungen AG.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Veterinary Endoscopes Market is Likely to Reach US$ 728.1 Million by the End of 2025

According to TMR, the global veterinary endoscopes market is likely to reach US$728.1 mn by the end of 2025, as against US$405.1 mn in 2016. Between 2017 and 2025, the global veterinary endoscopes market is likely to show a CAGR of 6.7%. In terms of animal, the demand for veterinary endoscopes is likely to be the highest from the companion animal segment. Among end users, hospitals beat the veterinary clinics segment to emerge at the market’s fore. Regionally, the global veterinary endoscopes market was led by North America in 2016. However, during the forecast period, lucrative opportunities witnessed in Asia Pacific is likely to be higher.

Report Overview @ https://www.transparencymarketresearch.com/veterinary-endoscopes-market.html

The healthcare sector has showcased several breakthroughs in the recent past. From finding cure for chronic ailments to dealing with the looming patent expiries, the research and development activities in this sector has been astounding. Besides launch of myriad novel therapeutics aimed at offering improved human health, developments in veterinary medical science have been commendable as well. The world witnessed the launch of several diagnostic and treatment methods aimed at offering advanced healthcare for animals.

In addition, several cutting-edge medical devices were launched in the field. Among these were the novel endoscopic techniques, developed to offer pets less painful and minimally-invasive alternatives to traditional open surgery. With people willing to spend on effective treatment for their pets, the demand for veterinary endoscopes has surged significantly in the last few years. Given the scenario, the rising adoption of pets and domestication of animals will provide considerable boost to the global veterinary endoscopes market.

Furthermore, animal protection laws have become increasingly stringent across the world. This is aimed at curbing atrocities meted on animals. As a matter of fact, these laws also gave impetus to veterinary treatments and medications, which has created newer growth avenues for the global veterinary endoscopes market. Also strong involvement of various non-government organizations in animal welfare and healthcare has upped the demand for effective veterinary treatment across the world. Spurred by steps taken by governments to curb animal cruelty and conserve wildlife, the global veterinary endoscopes market will find lucrative growth opportunities in the coming years.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30518

The recent advancements in veterinary endoscopy offers improved view of animal organs. Because of these advancements, faster recovery has become possible. Besides this, veterinary endoscopes enable accessing the other inaccessible organs within an animal body. While these factors will enable the market register strong growth in the coming years, limited penetration in emerging and underdeveloped nations will slacken its pace of growth to a limit. Furthermore, inadequate knowledge about veterinary endoscope in these countries may also create hindrances for the market, besides cost constraint. The high cost of these devices will also act as a negative factor, adversely affecting the global veterinary endoscope market’s growth prospects.

A recent study by Transparency Market Research (TMR) offers insights into various strategies that players within the global veterinary endoscopes market adopt to gain competitive edge. Companies such as Harvard Bioscience Infiniti Medical, Olympus Corporation, Fujifilm Holdings Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, STERIS plc, ESS, Inc., Jorgen Kruuse A/S, and HOYA Corporation (PENTAX Medical) are some of the key players operating in the global market. In order to gain a competitive edge, these companies majorly rely on strategic collaborations, mergers and acquisitions, product launches, and research and development. Besides these, investment in innovations form an important inclusion in their strategies aimed at giving considerable boost to their ongoing business.

Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=30518&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Collateral Ligament Stabilizer System Market Growth Opportunities and Forecast Up to 2025

A ligament is a band of tissue that connects bone to bone. The collateral ligaments are located on the outside of the knee joint. These ligaments help to connect the bones of the upper and lower leg inside the knee joint. There are four primary ligaments in the knee. These ligaments act like strong ropes holding the bones together and keeping the knee stable. The medial collateral ligament is present on the sides of the knee which connect the femur to the tibia. The lateral collateral ligament connects the femur to the smaller bone in the lower leg. This ligament controls the side motion of the knee and prevents the knee against unusual movement. It can be injured by exertion of the knee and through non-contact injury such as hyperextension stress.

Report Overview @ https://www.transparencymarketresearch.com/collateral-ligament-stabilizer-system-market.html

A collateral ligament injury occurs when the ligaments are stretched or torn. A partial tear occurs when only a part of the ligament is torn. A complete tear occurs when the entire ligament is torn into two pieces. Injuries to lateral knee structures are less common than injuries to medial knee structures but lateral knee injuries may be more disabling because these structures are subjected to greater force during gait. The prominence of games, especially those including valgus knee stacking such as ice hockey, skiing, and football, has added to the successive occurrence of medial collateral ligament injuries.

The global market for collateral ligament stabilizer system is driven by growing prevalence of orthopedic diseases such as knee arthritis and rising geriatric population with low calcium density in the knee bone that leads to facture. However, high cost involved in the knee surgical and knee replacement is likely to hamper the growth of the market during the forecast period.

Based on ligament type, the global collateral ligament stabilizer system market is divided into medial collateral ligament and lateral collateral ligament. The medial collateral ligament segment is projected to expand at a significant growth rate as it is the most common ligamentous knee injury. In terms of imaging test, the market is categorized into magnetic resonance imaging, valgus stress test, and x-rays. The magnetic resonance imaging segment is growing at a faster rate than other segments due to its accurate and cost-effective means of evaluating a wide spectrum of knee injuries, ranging from cruciate-collateral ligament injuries to cartilage deficiencies of any age. In terms of treatment, the market is segmented into surgical treatment and non-surgical treatment.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31487

Surgical treatment such as arthroscopy surgery is growing at a significant rate as compared to other types of non-surgical treatment such as physiotherapy and bracing. The surgical healing rate is high within a short time of period and this attribute to growth of the segment. In terms of end-user, the market is classified into hospitals and orthopedic clinics. The hospitals segment holds a significant market share which is attributed to increasing patient preference due to availability of a wide range of tools, tests, and orthopedic surgeons under one roof.

Geographically, the collateral ligament stabilizer system market is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe are expected to be the largest markets due to large geriatric population. Moreover, incidence of musculoskeletal disorders such as carpal tunnel syndrome is higher in these regions. The Asia Pacific market is expected to grow significantly during the forecast period due to growth of health care expenditure, rise in the number of health care facilities, and increase in sports injuries. The market growth in Middle East & Africa is driven by growing income and increasing prevalence of osteoarthritis.

Key players operating in the global collateral ligament stabilizer system market include DePuy Synthes, Arthrex, Bauerfeind, DJO Global LLC, and DeRoyal Industries Inc.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=31487&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Central Venous Catheter Market Key Growth Factors and Forecast Up to 2025

Central venous catheter is a thin, flexible tube (catheter) that is placed into the large vein above the heart, usually through a vein in the neck, chest, or arm. It’s also called the central venous line or central line. Central venous catheters are used to administer chemotherapy drugs, intravenous (IV) fluids, antibiotics, blood and platelet transfusions, parenteral nutrition, etc. The peripherally inserted catheter is the commonly used central venous catheter due to several advantages such as easy to insert and remove, easy to repair. Central venous catheters need special care. They may require regular cleaning or dressing employing sterile techniques. Central venous access is a commonly performed procedure with about 8% of hospitalized patients needing central venous access during the course of their hospital stay. More than five million central venous catheters are inserted in the U.S. each year.

Report Overview @ https://www.transparencymarketresearch.com/central-venous-catheter-market.html

Rising adoption and increasing demand for antimicrobial-coated catheters, rising number of chronic diseases such as cancer, end-stage renal disease and others, increasing geriatric population, and rising usage of tip location devices are anticipatead to drive the global central venous catheter market. Other factors such as favorable insurance and reimbursement policies, technological innovation, and early adoption of diagnostic procedures are likely to fuel the overall central venous catheter market. According to the U.S. Department of Health and Human Services, national expenditures for cancer treatment in the U.S. was nearly US$ 125 billion in 2010 and is estimated to reach US$ 156 billion by 2020. On the other hand, the risks associated with catheters and pricing pressure are projected to hinder the expansion of the global central venous catheter market.

The central venous catheter market has been segmented based on product type, route of insertion, application, end-user and region. In terms of product type, the market can be segmented into peripherally-inserted central catheter (PICC), non-tunneled catheters, tunneled catheter, and implanted port. In terms of route of insertion, the central venous catheter market can be segmented into intravenous and subcutaneous. Based on application, the central venous catheter market can be segmented into medication administration, administration of fluid and nutrition, transfusion of blood products, and diagnostic testing. In terms of end-user, the market can be segmented into hospitals, clinics, ambulatory surgery centers, and diagnostic centers.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31340

In terms of region, the central venous catheter market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

North America dominates the global central venous catheter market due to technological advancement, rising prevalence of cancer, cardiovascular and end stage renal diseases, and rising geriatric population. According to the American Cancer Society, about 1,688,780 new cancer cases are expected to be diagnosed in 2017 in the U.S. Europe is the second largest market for central venous catheter due to increasing number of patients undergoing dialysis and transfusion of blood products, and rising lifestyle diseases. The central venous catheter market in Asia Pacific is estimated to expand at higher rate due to the large population base, high target patient pool, increasing government initiatives to provide better healthcare facilities, rising disposable income, and per capita health care expenditure. According to the World Health Organization, Singapore ranks sixth, globally, for its advanced healthcare system and offers the fourth best healthcare infrastructure in the world. Demand for advanced medical technologies is anticipated to strengthen its reputation as a healthcare hub in the region.

Major players operating in the global central venous catheter market include B. Braun Melsungen AG, Becton, Dickinson and Company, C. R. Bard, Cook Medical, Teleflex Incorporated, Siemens Healthineers, and AngioDynamics, Inc.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=31340&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Cytology Devices Market Comprehensive Analysis and Future Estimations 2025

Cytology is a branch of pathology that deals with the study of physical, chemical, and functional characters of cells. Cytology is one of the leading diagnostic methods used for detection of cancer. Cytology collection involves extracting cells from various body parts by using specialized devices. These specimens are further processed by cytology testing devices in pathology laboratories to evaluate the presence of a disease. Cytology specimens are collected from body parts such as the oral cavity, the gastrointestinal tract, the cervical tract, and the respiratory tract and from plural fluid, pericardial fluid, and spinal fluid. Most of the cytology collection techniques are non-invasive; however, some apply invasive or surgical techniques to collect the specimen. Selection of the cytology device depends on the application area and specimen requirements.

Report Overview @ https://www.transparencymarketresearch.com/cytology-devices-market.html

Cancer detection is one of the widely applied areas of cytology. According to the World Health Organization (WHO), 14 million new cancer cases were diagnosed in 2012 and the number of new cases is estimated to rise by 70% by 2035. High prevalence of cancer across the globe is estimated to increase the adoption of cytology devices for conducting cytology tests. Technical advancements in the field of cytology such as automated cytology analyzers and point-of-care testing devices are estimated to fuel the cytology devices market during the forecast period.

Increasing efficiency and availability of advanced collection devices such as aspiration needles for collection of liver and pancreas specimens is projected to propel the cytology devices market from 2017 to 2025. However, availability of low-quality and inexpensive cytology devices in regional marketplaces is anticipated to hamper the cytology devices market. Moreover, developments in alternative therapies such as immunoassays and molecular diagnostics is likely to hamper the market from 2017 to 2025.

The global cytology devices market can be segmented based on product, application, end-user, and region. In terms of product, the market can be divided into brushes, spatulas, aspiration needles, and others. The brushes segment can be sub-divided into metallic and plastic brushes. The others segment comprises cytology devices such as currets and cervical brooms. The brushes segment is anticipated to hold a leading share of the global cytology devices market from 2017 to 2025. The aspiration needles segment is anticipated to witness high growth during the forecast period, owing to their rising usage in the collection of liver, pancreas, and breast specimens as well as plural fluids and spinal fluids. Based on application, the global cytology devices market can be segmented into pulmonology, gastroenterology, gynecology, and others.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36158

High prevalence of cervical cancer and launch of new products for the treatment of cervical cancer are factors estimated to fuel the gynecology segment during the forecast period. Technological advancements in the field of gastroenterology such as new endoscopy systems and ultrasound endoscopy are projected to contribute to high growth of the gastroenterology segment. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. The diagnostic laboratories segment is likely to account for a leading share of the global cytology devices market during the forecast period.

Geographically, the global cytology devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to constitute a leading share of the global market during the forecast period, owing to high number of cytology tests being performed in the region. Europe is anticipated to account for a significant share of the global market between 2017 and 2025. According to the World Health Organization (WHO), around 3.7 million new cases of cancer were registered in Europe in 2012. The market in Asia Pacific is projected to witness high growth during the forecast period, owing to increasing health care expenditure in the region.

Major players operating in the global cytology devices market are Biocytech Corporation, RI.MOS. srl, CONMED Corporation, Olympus Corporation, MEDI-GLOBE CORPORATION, US Endoscopy (a part of STERIS Corporation), ENDO-FLEX GmbH, Nipro, and STERYLAB S.r.l.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=36158&ltype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com